Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)

Mezzion Pharma Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	16,081	13,617	40,246	29,399	24,210	35,854
Short-Term Investments	5,000	15,000	18,000	3,000	23,284	13,250
Cash & Short-Term Investments	21,081	28,617	58,246	32,399	47,494	49,104
Cash Growth	-60.70%	-50.87%	79.78%	-31.78%	-3.28%	19.30%
Accounts Receivable	1,133	869.93	2,309	2,644	2,368	2,565
Other Receivables	198.61	457.47	2,154	238.76	377.57	223.51
Receivables	1,762	1,757	5,925	4,203	4,435	4,248
Inventory	5,436	5,420	5,742	8,835	11,777	7,011
Prepaid Expenses	172.28	127.5	136.44	265.05	266.77	238.94
Other Current Assets	6,541	6,004	4,194	195.28	201.3	66.81
Total Current Assets	34,993	41,926	74,244	45,897	64,174	60,669
Property, Plant & Equipment	2,378	2,529	2,854	4,245	4,879	5,899
Long-Term Investments	3.47	3.08	7.46	-	-0	0
Other Intangible Assets	1,620	1,620	1,620	1,620	1,620	1,620
Long-Term Deferred Charges	30,783	26,820	11,324	-	12,559	6,622
Other Long-Term Assets	773.01	821.1	1,951	1,950	672.93	656.16
Total Assets	70,839	73,998	92,149	54,022	83,935	75,625
Accounts Payable	1,693	1,646	4,030	7,173	5,503	3,466
Accrued Expenses	19,751	18,882	21,831	-	7,188	5,533
Short-Term Debt	-	-	499.58	1,063	932.01	985.5
Current Portion of Leases	596.02	694.38	735.87	-	1,051	1,015
Current Income Taxes Payable	2,744	3,892	-	-	-	803.65
Other Current Liabilities	1,566	1,556	2,519	17,844	3,823	3,711
Total Current Liabilities	26,350	26,670	29,615	26,080	18,497	15,514
Long-Term Leases	884.88	921.47	1,005	-	2,338	3,104
Long-Term Deferred Tax Liabilities	251.42	251.42	-	-	-	-
Other Long-Term Liabilities	93.87	91.98	84.61	1,702	89.78	88.78
Total Liabilities	27,580	27,935	30,705	27,782	21,141	18,816
Common Stock	15,004	14,982	14,804	13,371	4,451	4,446
Additional Paid-In Capital	159,797	159,062	150,510	99,256	107,802	107,530
Retained Earnings	-146,467	-143,148	-123,723	-111,052	-74,789	-61,166
Comprehensive Income & Other	14,926	15,167	19,854	24,665	25,330	5,999
Shareholders' Equity	43,259	46,063	61,444	26,240	62,793	56,810
Total Liabilities & Equity	70,839	73,998	92,149	54,022	83,935	75,625
Total Debt	1,481	1,616	2,241	1,063	4,321	5,104
Net Cash (Debt)	19,600	27,001	56,006	31,336	43,173	44,000
Net Cash Growth	-62.44%	-51.79%	78.73%	-27.42%	-1.88%	17.14%
Net Cash Per Share	655.36	905.33	1983.28	1172.20	1617.75	1692.10
Filing Date Shares Outstanding	30.01	29.96	29.61	26.74	26.7	26.68
Total Common Shares Outstanding	30.01	29.96	29.61	26.74	26.7	26.68
Working Capital	8,643	15,255	44,628	19,817	45,678	45,155
Book Value Per Share	1441.63	1537.30	2075.31	981.23	2351.55	2129.45
Tangible Book Value	41,640	44,443	59,825	24,620	61,174	55,190
Tangible Book Value Per Share	1387.65	1483.24	2020.60	920.66	2290.89	2068.74
Buildings	-	-	-	23.97	23.97	7.97
Machinery	-	2,191	1,976	3,523	2,908	2,652
Construction In Progress	-	-	619.69	439.17	193.43	-

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.